Trials / Completed
CompletedNCT00347022
A Clinical Study of Xenetix 300 in Multislice Computed Tomography (CT) Pediatric Indications
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 145 (actual)
- Sponsor
- Guerbet · Industry
- Sex
- All
- Age
- 1 Year – 16 Years
- Healthy volunteers
- Not accepted
Summary
This is a clinical study of Xenetix 300 in Multislice Computed Tomography (MSCT) in pediatric indications.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Xenetix | 300 mg of iodine/ml |
| DRUG | Visipaque | 270 mg of iodine/ml |
Timeline
- Start date
- 2006-05-01
- Primary completion
- 2009-04-01
- Completion
- 2009-06-01
- First posted
- 2006-07-04
- Last updated
- 2013-04-09
- Results posted
- 2013-04-09
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT00347022. Inclusion in this directory is not an endorsement.